Synergy Asset Management, LLC Abb Vie Inc. Transaction History

Synergy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $2.64 Million - $3.08 Million	17,035 New	17,035 $2.92 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $581,263 - $666,670	4,331 Added 30.59%	18,487 $2.48 Million
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $1.95 Million - $2.48 Million	14,156 New	14,156 $2.17 Million
Q3 2021 Nov 10, 2021	SELL	$106.4 - $120.78 $1.28 Million - $1.45 Million	-12,020 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $1.74 Million - $1.93 Million	-16,504 Reduced 57.86%	12,020 $1.35 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $206,952 - $227,830	-2,023 Reduced 6.62%	28,524 $3.09 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $2.46 Million - $3.32 Million	30,547 New	30,547 $3.27 Million

3,817

1.25B

13M

10M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Synergy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Synergy Asset Management, LLC with notifications on news.